Physician profile
Nicole E Fox
NPI 1982938395
$554.66
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $513 · 2022: $41.57.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $143.06 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $127.21 | 2021-2022 | |
| Adamas Pharmaceuticals, INC. | $34.76 | 2021 | |
| Mallinckrodt Hospital Products INC. | $27.88 | 2021 | |
| Amgen INC. | $26.27 | 2021 | |
| Genentech USA, INC. | $24.77 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $19.13 | 2021 | |
| Emd Serono, INC. | $18.52 | 2021 | |
| Lilly USA, LLC | $18.25 | 2021 | |
| Lundbeck LLC | $16.80 | 2021 | |
| Acorda Therapeutics, INC | $15.50 | 2021 | |
| Avanir Pharmaceuticals, INC. | $14.98 | 2021 | |
| Eisai INC. | $14.39 | 2021 | |
| Genzyme Corporation | $13.84 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.52 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $13.19 | 2021 | |
| Allergan, INC. | $12.59 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.